Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some ...

Alopecia areata, an autoimmune condition, leads to patchy hair loss due to immune system attacks on hair follicles. Garlic, with its allicin and sulfu ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

AA is linked to increased anxiety and depression, especially in females and younger patients, with variations across countries. The study found significant associations between AA and mental health in ...

A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...

Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

Discover 6 shocking truths about sudden hair loss and alopecia areata. Learn life-changing strategies that restore confidence and promote regrowth.

Sun Pharma settles litigation with Incyte over Leqselvi, launches product for severe alopecia areata treatment in the US.